MedTrace Logo

A Study to Assess the Validation and Mapping of the Suicide Ideation and Behavior Assessment

NCT03085108 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2025-02-03

No results posted yet for this study

Summary

The main purpose of this cross-sectional study is to generate data to support the psychometric properties of the Suicide Ideation and Behavior Assessment Tool (SIBAT) and validate its use in participants at imminent risk of suicide.

Conditions

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • Janssen Scientific Affairs, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Scientific Affairs, LLC Clinical Trial · Janssen Scientific Affairs, LLC

Eligibility

Min Age
12 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-31
Primary Completion
2017-11-14
Completion
2017-11-14

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03085108 on ClinicalTrials.gov